Asia-Pacific Patient Derived Xenograft/PDX Models Market Report 2017

October 2017 | 111 pages | ID: AFD7B9E7015WEN
QYResearch

Abstracts

In this report, the Asia-Pacific Patient Derived Xenograft/PDX Models market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split Asia-Pacific into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Patient Derived Xenograft/PDX Models for these regions, from 2012 to 2022 (forecast), including

• China
• Japan
• South Korea
• Taiwan
• India
• Southeast Asia
• Australia

Asia-Pacific Patient Derived Xenograft/PDX Models market competition by top manufacturers/players, with Patient Derived Xenograft/PDX Models sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Crown Bioscience Inc.
• the Jackson Laboratory
• Champions Oncology, Inc.
• Charles River Laboratories International, Inc.
• WuXi Apptec
• ONCODESIGN
• Horizon Discovery Group PLC
• Pharmatest Services Ltd.
• Hera Biolabs
• EPO Berlin-Buch GmbH
• Xentech
• Urolead

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into

• Gastrointestinal Tumor Models
• Gynecological Tumor Models
• Respiratory Tumor Models
• Urological Tumor Models
• Hematological Tumor Models
• Other Tumor Models

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Patient Derived Xenograft/PDX Models for each application, includin

• Preclinical Drug Development and Basic Cancer Research
• Biomarker Analysis

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Asia-Pacific Patient Derived Xenograft/PDX Models Market Report 2017

1 PATIENT DERIVED XENOGRAFT/PDX MODELS OVERVIEW

1.1 Product Overview and Scope of Patient Derived Xenograft/PDX Models
1.2 Classification of Patient Derived Xenograft/PDX Models by Product Category
  1.2.1 Asia-Pacific Patient Derived Xenograft/PDX Models Market Size (Sales) Comparison by Types (2012-2022)
  1.2.2 Asia-Pacific Patient Derived Xenograft/PDX Models Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Gastrointestinal Tumor Models
  1.2.4 Gynecological Tumor Models
  1.2.5 Respiratory Tumor Models
  1.2.6 Urological Tumor Models
  1.2.7 Hematological Tumor Models
  1.2.8 Other Tumor Models
1.3 Asia-Pacific Patient Derived Xenograft/PDX Models Market by Application/End Users
  1.3.1 Asia-Pacific Patient Derived Xenograft/PDX Models Sales (Volume) and Market Share Comparison by Applications (2012-2022)
  1.3.2 Preclinical Drug Development and Basic Cancer Research
  1.3.3 Biomarker Analysis
1.4 Asia-Pacific Patient Derived Xenograft/PDX Models Market by Region
  1.4.1 Asia-Pacific Patient Derived Xenograft/PDX Models Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 China Status and Prospect (2012-2022)
  1.4.3 Japan Status and Prospect (2012-2022)
  1.4.4 South Korea Status and Prospect (2012-2022)
  1.4.5 Taiwan Status and Prospect (2012-2022)
  1.4.6 India Status and Prospect (2012-2022)
  1.4.7 Southeast Asia Status and Prospect (2012-2022)
  1.4.8 Australia Status and Prospect (2012-2022)
1.5 Asia-Pacific Market Size (Value and Volume) of Patient Derived Xenograft/PDX Models (2012-2022)
  1.5.1 Asia-Pacific Patient Derived Xenograft/PDX Models Sales and Growth Rate (2012-2022)
  1.5.2 Asia-Pacific Patient Derived Xenograft/PDX Models Revenue and Growth Rate (2012-2022)

2 ASIA-PACIFIC PATIENT DERIVED XENOGRAFT/PDX MODELS COMPETITION BY PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 Asia-Pacific Patient Derived Xenograft/PDX Models Market Competition by Players/Suppliers
  2.1.1 Asia-Pacific Patient Derived Xenograft/PDX Models Sales Volume and Market Share of Key Players/Suppliers (2012-2017)
  2.1.2 Asia-Pacific Patient Derived Xenograft/PDX Models Revenue and Share by Players/Suppliers (2012-2017)
2.2 Asia-Pacific Patient Derived Xenograft/PDX Models (Volume and Value) by Type
  2.2.1 Asia-Pacific Patient Derived Xenograft/PDX Models Sales and Market Share by Type (2012-2017)
  2.2.2 Asia-Pacific Patient Derived Xenograft/PDX Models Revenue and Market Share by Type (2012-2017)
2.3 Asia-Pacific Patient Derived Xenograft/PDX Models (Volume) by Application
2.4 Asia-Pacific Patient Derived Xenograft/PDX Models (Volume and Value) by Region
  2.4.1 Asia-Pacific Patient Derived Xenograft/PDX Models Sales and Market Share by Region (2012-2017)
  2.4.2 Asia-Pacific Patient Derived Xenograft/PDX Models Revenue and Market Share by Region (2012-2017)

3 CHINA PATIENT DERIVED XENOGRAFT/PDX MODELS (VOLUME, VALUE AND SALES PRICE)

3.1 China Patient Derived Xenograft/PDX Models Sales and Value (2012-2017)
  3.1.1 China Patient Derived Xenograft/PDX Models Sales Volume and Growth Rate (2012-2017)
  3.1.2 China Patient Derived Xenograft/PDX Models Revenue and Growth Rate (2012-2017)
  3.1.3 China Patient Derived Xenograft/PDX Models Sales Price Trend (2012-2017)
3.2 China Patient Derived Xenograft/PDX Models Sales Volume and Market Share by Type
3.3 China Patient Derived Xenograft/PDX Models Sales Volume and Market Share by Application

4 JAPAN PATIENT DERIVED XENOGRAFT/PDX MODELS (VOLUME, VALUE AND SALES PRICE)

4.1 Japan Patient Derived Xenograft/PDX Models Sales and Value (2012-2017)
  4.1.1 Japan Patient Derived Xenograft/PDX Models Sales Volume and Growth Rate (2012-2017)
  4.1.2 Japan Patient Derived Xenograft/PDX Models Revenue and Growth Rate (2012-2017)
  4.1.3 Japan Patient Derived Xenograft/PDX Models Sales Price Trend (2012-2017)
4.2 Japan Patient Derived Xenograft/PDX Models Sales Volume and Market Share by Type
4.3 Japan Patient Derived Xenograft/PDX Models Sales Volume and Market Share by Application

5 SOUTH KOREA PATIENT DERIVED XENOGRAFT/PDX MODELS (VOLUME, VALUE AND SALES PRICE)

5.1 South Korea Patient Derived Xenograft/PDX Models Sales and Value (2012-2017)
  5.1.1 South Korea Patient Derived Xenograft/PDX Models Sales Volume and Growth Rate (2012-2017)
  5.1.2 South Korea Patient Derived Xenograft/PDX Models Revenue and Growth Rate (2012-2017)
  5.1.3 South Korea Patient Derived Xenograft/PDX Models Sales Price Trend (2012-2017)
5.2 South Korea Patient Derived Xenograft/PDX Models Sales Volume and Market Share by Type
5.3 South Korea Patient Derived Xenograft/PDX Models Sales Volume and Market Share by Application

6 TAIWAN PATIENT DERIVED XENOGRAFT/PDX MODELS (VOLUME, VALUE AND SALES PRICE)

6.1 Taiwan Patient Derived Xenograft/PDX Models Sales and Value (2012-2017)
  6.1.1 Taiwan Patient Derived Xenograft/PDX Models Sales Volume and Growth Rate (2012-2017)
  6.1.2 Taiwan Patient Derived Xenograft/PDX Models Revenue and Growth Rate (2012-2017)
  6.1.3 Taiwan Patient Derived Xenograft/PDX Models Sales Price Trend (2012-2017)
6.2 Taiwan Patient Derived Xenograft/PDX Models Sales Volume and Market Share by Type
6.3 Taiwan Patient Derived Xenograft/PDX Models Sales Volume and Market Share by Application

7 INDIA PATIENT DERIVED XENOGRAFT/PDX MODELS (VOLUME, VALUE AND SALES PRICE)

7.1 India Patient Derived Xenograft/PDX Models Sales and Value (2012-2017)
  7.1.1 India Patient Derived Xenograft/PDX Models Sales Volume and Growth Rate (2012-2017)
  7.1.2 India Patient Derived Xenograft/PDX Models Revenue and Growth Rate (2012-2017)
  7.1.3 India Patient Derived Xenograft/PDX Models Sales Price Trend (2012-2017)
7.2 India Patient Derived Xenograft/PDX Models Sales Volume and Market Share by Type
7.3 India Patient Derived Xenograft/PDX Models Sales Volume and Market Share by Application

8 SOUTHEAST ASIA PATIENT DERIVED XENOGRAFT/PDX MODELS (VOLUME, VALUE AND SALES PRICE)

8.1 Southeast Asia Patient Derived Xenograft/PDX Models Sales and Value (2012-2017)
  8.1.1 Southeast Asia Patient Derived Xenograft/PDX Models Sales Volume and Growth Rate (2012-2017)
  8.1.2 Southeast Asia Patient Derived Xenograft/PDX Models Revenue and Growth Rate (2012-2017)
  8.1.3 Southeast Asia Patient Derived Xenograft/PDX Models Sales Price Trend (2012-2017)
8.2 Southeast Asia Patient Derived Xenograft/PDX Models Sales Volume and Market Share by Type
8.3 Southeast Asia Patient Derived Xenograft/PDX Models Sales Volume and Market Share by Application

9 AUSTRALIA PATIENT DERIVED XENOGRAFT/PDX MODELS (VOLUME, VALUE AND SALES PRICE)

9.1 Australia Patient Derived Xenograft/PDX Models Sales and Value (2012-2017)
  9.1.1 Australia Patient Derived Xenograft/PDX Models Sales Volume and Growth Rate (2012-2017)
  9.1.2 Australia Patient Derived Xenograft/PDX Models Revenue and Growth Rate (2012-2017)
  9.1.3 Australia Patient Derived Xenograft/PDX Models Sales Price Trend (2012-2017)
9.2 Australia Patient Derived Xenograft/PDX Models Sales Volume and Market Share by Type
9.3 Australia Patient Derived Xenograft/PDX Models Sales Volume and Market Share by Application

10 ASIA-PACIFIC PATIENT DERIVED XENOGRAFT/PDX MODELS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

10.1 Crown Bioscience Inc.
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Patient Derived Xenograft/PDX Models Product Category, Application and Specification
    10.1.2.1 Product A
    10.1.2.2 Product B
  10.1.3 Crown Bioscience Inc. Patient Derived Xenograft/PDX Models Sales, Revenue, Price and Gross Margin (2012-2017)
  10.1.4 Main Business/Business Overview
10.2 the Jackson Laboratory
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Patient Derived Xenograft/PDX Models Product Category, Application and Specification
    10.2.2.1 Product A
    10.2.2.2 Product B
  10.2.3 the Jackson Laboratory Patient Derived Xenograft/PDX Models Sales, Revenue, Price and Gross Margin (2012-2017)
  10.2.4 Main Business/Business Overview
10.3 Champions Oncology, Inc.
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Patient Derived Xenograft/PDX Models Product Category, Application and Specification
    10.3.2.1 Product A
    10.3.2.2 Product B
  10.3.3 Champions Oncology, Inc. Patient Derived Xenograft/PDX Models Sales, Revenue, Price and Gross Margin (2012-2017)
  10.3.4 Main Business/Business Overview
10.4 Charles River Laboratories International, Inc.
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Patient Derived Xenograft/PDX Models Product Category, Application and Specification
    10.4.2.1 Product A
    10.4.2.2 Product B
  10.4.3 Charles River Laboratories International, Inc. Patient Derived Xenograft/PDX Models Sales, Revenue, Price and Gross Margin (2012-2017)
  10.4.4 Main Business/Business Overview
10.5 WuXi Apptec
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Patient Derived Xenograft/PDX Models Product Category, Application and Specification
    10.5.2.1 Product A
    10.5.2.2 Product B
  10.5.3 WuXi Apptec Patient Derived Xenograft/PDX Models Sales, Revenue, Price and Gross Margin (2012-2017)
  10.5.4 Main Business/Business Overview
10.6 ONCODESIGN
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Patient Derived Xenograft/PDX Models Product Category, Application and Specification
    10.6.2.1 Product A
    10.6.2.2 Product B
  10.6.3 ONCODESIGN Patient Derived Xenograft/PDX Models Sales, Revenue, Price and Gross Margin (2012-2017)
  10.6.4 Main Business/Business Overview
10.7 Horizon Discovery Group PLC
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Patient Derived Xenograft/PDX Models Product Category, Application and Specification
    10.7.2.1 Product A
    10.7.2.2 Product B
  10.7.3 Horizon Discovery Group PLC Patient Derived Xenograft/PDX Models Sales, Revenue, Price and Gross Margin (2012-2017)
  10.7.4 Main Business/Business Overview
10.8 Pharmatest Services Ltd.
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Patient Derived Xenograft/PDX Models Product Category, Application and Specification
    10.8.2.1 Product A
    10.8.2.2 Product B
  10.8.3 Pharmatest Services Ltd. Patient Derived Xenograft/PDX Models Sales, Revenue, Price and Gross Margin (2012-2017)
  10.8.4 Main Business/Business Overview
10.9 Hera Biolabs
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 Patient Derived Xenograft/PDX Models Product Category, Application and Specification
    10.9.2.1 Product A
    10.9.2.2 Product B
  10.9.3 Hera Biolabs Patient Derived Xenograft/PDX Models Sales, Revenue, Price and Gross Margin (2012-2017)
  10.9.4 Main Business/Business Overview
10.10 EPO Berlin-Buch GmbH
  10.10.1 Company Basic Information, Manufacturing Base and Competitors
  10.10.2 Patient Derived Xenograft/PDX Models Product Category, Application and Specification
    10.10.2.1 Product A
    10.10.2.2 Product B
  10.10.3 EPO Berlin-Buch GmbH Patient Derived Xenograft/PDX Models Sales, Revenue, Price and Gross Margin (2012-2017)
  10.10.4 Main Business/Business Overview
10.11 Xentech
10.12 Urolead

11 PATIENT DERIVED XENOGRAFT/PDX MODELS MANUFACTURING COST ANALYSIS

11.1 Patient Derived Xenograft/PDX Models Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Patient Derived Xenograft/PDX Models

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 Patient Derived Xenograft/PDX Models Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Patient Derived Xenograft/PDX Models Major Manufacturers in 2016
12.4 Downstream Buyers

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 MARKET EFFECT FACTORS ANALYSIS

14.1 Technology Progress/Risk
  14.1.1 Substitutes Threat
  14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change

15 ASIA-PACIFIC PATIENT DERIVED XENOGRAFT/PDX MODELS MARKET FORECAST (2017-2022)

15.1 Asia-Pacific Patient Derived Xenograft/PDX Models Sales Volume, Revenue and Price Forecast (2017-2022)
  15.1.1 Asia-Pacific Patient Derived Xenograft/PDX Models Sales Volume and Growth Rate Forecast (2017-2022)
  15.1.2 Asia-Pacific Patient Derived Xenograft/PDX Models Revenue and Growth Rate Forecast (2017-2022)
  15.1.3 Asia-Pacific Patient Derived Xenograft/PDX Models Price and Trend Forecast (2017-2022)
15.2 Asia-Pacific Patient Derived Xenograft/PDX Models Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
  15.2.1 Asia-Pacific Patient Derived Xenograft/PDX Models Sales Volume and Growth Rate Forecast by Region (2017-2022)
  15.2.2 Asia-Pacific Patient Derived Xenograft/PDX Models Revenue and Growth Rate Forecast by Region (2017-2022)
  15.2.3 China Patient Derived Xenograft/PDX Models Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.4 Japan Patient Derived Xenograft/PDX Models Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.5 South Korea Patient Derived Xenograft/PDX Models Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.6 Taiwan Patient Derived Xenograft/PDX Models Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.7 India Patient Derived Xenograft/PDX Models Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.8 Southeast Asia Patient Derived Xenograft/PDX Models Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.9 Australia Patient Derived Xenograft/PDX Models Sales, Revenue and Growth Rate Forecast (2017-2022)
15.3 Asia-Pacific Patient Derived Xenograft/PDX Models Sales, Revenue and Price Forecast by Type (2017-2022)
  15.3.1 Asia-Pacific Patient Derived Xenograft/PDX Models Sales Forecast by Type (2017-2022)
  15.3.2 Asia-Pacific Patient Derived Xenograft/PDX Models Revenue Forecast by Type (2017-2022)
  15.3.3 Asia-Pacific Patient Derived Xenograft/PDX Models Price Forecast by Type (2017-2022)
15.4 Asia-Pacific Patient Derived Xenograft/PDX Models Sales Forecast by Application (2017-2022)

16 RESEARCH FINDINGS AND CONCLUSION

17 APPENDIX

17.1 Methodology/Research Approach
  17.1.1 Research Programs/Design
  17.1.2 Market Size Estimation
  17.1.3 Market Breakdown and Data Triangulation
17.2 Data Source
  17.2.1 Secondary Sources
  17.2.2 Primary Sources
17.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Patient Derived Xenograft/PDX Models
Figure Asia-Pacific Patient Derived Xenograft/PDX Models Sales Volume (K Units) by Type (2012-2022)
Figure Asia-Pacific Patient Derived Xenograft/PDX Models Sales Volume Market Share by Type (Product Category) in 2016
Figure Gastrointestinal Tumor Models Product Picture
Figure Gynecological Tumor Models Product Picture
Figure Respiratory Tumor Models Product Picture
Figure Urological Tumor Models Product Picture
Figure Hematological Tumor Models Product Picture
Figure Other Tumor Models Product Picture
Figure Asia-Pacific Patient Derived Xenograft/PDX Models Sales (K Units) by Application (2012-2022)
Figure Asia-Pacific Sales Market Share of Patient Derived Xenograft/PDX Models by Application in 2016
Figure Preclinical Drug Development and Basic Cancer Research Examples
Table Key Downstream Customer in Preclinical Drug Development and Basic Cancer Research
Figure Biomarker Analysis Examples
Table Key Downstream Customer in Biomarker Analysis
Figure Asia-Pacific Patient Derived Xenograft/PDX Models Market Size (Million USD) by Region (2012-2022)
Figure China Patient Derived Xenograft/PDX Models Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Patient Derived Xenograft/PDX Models Revenue (Million USD) and Growth Rate (2012-2022)
Figure South Korea Patient Derived Xenograft/PDX Models Revenue (Million USD) and Growth Rate (2012-2022)
Figure Taiwan Patient Derived Xenograft/PDX Models Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Patient Derived Xenograft/PDX Models Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Patient Derived Xenograft/PDX Models Revenue (Million USD) and Growth Rate (2012-2022)
Figure Australia Patient Derived Xenograft/PDX Models Revenue (Million USD) and Growth Rate (2012-2022)
Figure Asia-Pacific Patient Derived Xenograft/PDX Models Sales Volume (K Units) and Growth Rate (2012-2022)
Figure Asia-Pacific Patient Derived Xenograft/PDX Models Revenue (Million USD) and Growth Rate (2012-2022)
Figure Asia-Pacific Patient Derived Xenograft/PDX Models Market Major Players Product Sales Volume (K Units)(2012-2017)
Table Asia-Pacific Patient Derived Xenograft/PDX Models Sales (K Units) of Key Players/Suppliers (2012-2017)
Table Asia-Pacific Patient Derived Xenograft/PDX Models Sales Share by Players/Suppliers (2012-2017)
Figure 2016 Asia-Pacific Patient Derived Xenograft/PDX Models Sales Share by Players/Suppliers
Figure 2017 Asia-Pacific Patient Derived Xenograft/PDX Models Sales Share by Players/Suppliers
Figure Asia-Pacific Patient Derived Xenograft/PDX Models Market Major Players Product Revenue (Million USD) 2012-2017
Table Asia-Pacific Patient Derived Xenograft/PDX Models Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Asia-Pacific Patient Derived Xenograft/PDX Models Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 Asia-Pacific Patient Derived Xenograft/PDX Models Revenue Share by Players
Figure 2017 Asia-Pacific Patient Derived Xenograft/PDX Models Revenue Share by Players
Table Asia-Pacific Patient Derived Xenograft/PDX Models Sales and Market Share by Type (2012-2017)
Table Asia-Pacific Patient Derived Xenograft/PDX Models Sales Share by Type (2012-2017)
Figure Sales Market Share of Patient Derived Xenograft/PDX Models by Type (2012-2017)
Figure Asia-Pacific Patient Derived Xenograft/PDX Models Sales Growth Rate by Type (2012-2017)
Table Asia-Pacific Patient Derived Xenograft/PDX Models Revenue (Million USD) and Market Share by Type (2012-2017)
Table Asia-Pacific Patient Derived Xenograft/PDX Models Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Patient Derived Xenograft/PDX Models by Type (2012-2017)
Figure Asia-Pacific Patient Derived Xenograft/PDX Models Revenue Growth Rate by Type (2012-2017)
Table Asia-Pacific Patient Derived Xenograft/PDX Models Sales Volume (K Units) and Market Share by Region (2012-2017)
Table Asia-Pacific Patient Derived Xenograft/PDX Models Sales Share by Region (2012-2017)
Figure Sales Market Share of Patient Derived Xenograft/PDX Models by Region (2012-2017)
Figure Asia-Pacific Patient Derived Xenograft/PDX Models Sales Market Share by Region in 2016
Table Asia-Pacific Patient Derived Xenograft/PDX Models Revenue (Million USD) and Market Share by Region (2012-2017)
Table Asia-Pacific Patient Derived Xenograft/PDX Models Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Patient Derived Xenograft/PDX Models by Region (2012-2017)
Figure Asia-Pacific Patient Derived Xenograft/PDX Models Revenue Market Share by Region in 2016
Table Asia-Pacific Patient Derived Xenograft/PDX Models Sales Volume (K Units) and Market Share by Application (2012-2017)
Table Asia-Pacific Patient Derived Xenograft/PDX Models Sales Share (%) by Application (2012-2017)
Figure Asia-Pacific Patient Derived Xenograft/PDX Models Sales Market Share by Application (2012-2017)
Figure Asia-Pacific Patient Derived Xenograft/PDX Models Sales Market Share by Application (2012-2017)
Figure China Patient Derived Xenograft/PDX Models Sales (K Units) and Growth Rate (2012-2017)
Figure China Patient Derived Xenograft/PDX Models Revenue (Million USD) and Growth Rate (2012-2017)
Figure China Patient Derived Xenograft/PDX Models Sales Price (USD/Unit) Trend (2012-2017)
Table China Patient Derived Xenograft/PDX Models Sales Volume (K Units) by Type (2012-2017)
Table China Patient Derived Xenograft/PDX Models Sales Volume Market Share by Type (2012-2017)
Figure China Patient Derived Xenograft/PDX Models Sales Volume Market Share by Type in 2016
Table China Patient Derived Xenograft/PDX Models Sales Volume (K Units) by Applications (2012-2017)
Table China Patient Derived Xenograft/PDX Models Sales Volume Market Share by Application (2012-2017)
Figure China Patient Derived Xenograft/PDX Models Sales Volume Market Share by Application in 2016
Figure Japan Patient Derived Xenograft/PDX Models Sales (K Units) and Growth Rate (2012-2017)
Figure Japan Patient Derived Xenograft/PDX Models Revenue (Million USD) and Growth Rate (2012-2017)
Figure Japan Patient Derived Xenograft/PDX Models Sales Price (USD/Unit) Trend (2012-2017)
Table Japan Patient Derived Xenograft/PDX Models Sales Volume (K Units) by Type (2012-2017)
Table Japan Patient Derived Xenograft/PDX Models Sales Volume Market Share by Type (2012-2017)
Figure Japan Patient Derived Xenograft/PDX Models Sales Volume Market Share by Type in 2016
Table Japan Patient Derived Xenograft/PDX Models Sales Volume (K Units) by Applications (2012-2017)
Table Japan Patient Derived Xenograft/PDX Models Sales Volume Market Share by Application (2012-2017)
Figure Japan Patient Derived Xenograft/PDX Models Sales Volume Market Share by Application in 2016
Figure South Korea Patient Derived Xenograft/PDX Models Sales (K Units) and Growth Rate (2012-2017)
Figure South Korea Patient Derived Xenograft/PDX Models Revenue (Million USD) and Growth Rate (2012-2017)
Figure South Korea Patient Derived Xenograft/PDX Models Sales Price (USD/Unit) Trend (2012-2017)
Table South Korea Patient Derived Xenograft/PDX Models Sales Volume (K Units) by Type (2012-2017)
Table South Korea Patient Derived Xenograft/PDX Models Sales Volume Market Share by Type (2012-2017)
Figure South Korea Patient Derived Xenograft/PDX Models Sales Volume Market Share by Type in 2016
Table South Korea Patient Derived Xenograft/PDX Models Sales Volume (K Units) by Applications (2012-2017)
Table South Korea Patient Derived Xenograft/PDX Models Sales Volume Market Share by Application (2012-2017)
Figure South Korea Patient Derived Xenograft/PDX Models Sales Volume Market Share by Application in 2016
Figure Taiwan Patient Derived Xenograft/PDX Models Sales (K Units) and Growth Rate (2012-2017)
Figure Taiwan Patient Derived Xenograft/PDX Models Revenue (Million USD) and Growth Rate (2012-2017)
Figure Taiwan Patient Derived Xenograft/PDX Models Sales Price (USD/Unit) Trend (2012-2017)
Table Taiwan Patient Derived Xenograft/PDX Models Sales Volume (K Units) by Type (2012-2017)
Table Taiwan Patient Derived Xenograft/PDX Models Sales Volume Market Share by Type (2012-2017)
Figure Taiwan Patient Derived Xenograft/PDX Models Sales Volume Market Share by Type in 2016
Table Taiwan Patient Derived Xenograft/PDX Models Sales Volume (K Units) by Applications (2012-2017)
Table Taiwan Patient Derived Xenograft/PDX Models Sales Volume Market Share by Application (2012-2017)
Figure Taiwan Patient Derived Xenograft/PDX Models Sales Volume Market Share by Application in 2016
Figure India Patient Derived Xenograft/PDX Models Sales (K Units) and Growth Rate (2012-2017)
Figure India Patient Derived Xenograft/PDX Models Revenue (Million USD) and Growth Rate (2012-2017)
Figure India Patient Derived Xenograft/PDX Models Sales Price (USD/Unit) Trend (2012-2017)
Table India Patient Derived Xenograft/PDX Models Sales Volume (K Units) by Type (2012-2017)
Table India Patient Derived Xenograft/PDX Models Sales Volume Market Share by Type (2012-2017)
Figure India Patient Derived Xenograft/PDX Models Sales Volume Market Share by Type in 2016
Table India Patient Derived Xenograft/PDX Models Sales Volume (K Units) by Application (2012-2017)
Table India Patient Derived Xenograft/PDX Models Sales Volume Market Share by Application (2012-2017)
Figure India Patient Derived Xenograft/PDX Models Sales Volume Market Share by Application in 2016
Figure Southeast Asia Patient Derived Xenograft/PDX Models Sales (K Units) and Growth Rate (2012-2017)
Figure Southeast Asia Patient Derived Xenograft/PDX Models Revenue (Million USD) and Growth Rate (2012-2017)
Figure Southeast Asia Patient Derived Xenograft/PDX Models Sales Price (USD/Unit) Trend (2012-2017)
Table Southeast Asia Patient Derived Xenograft/PDX Models Sales Volume (K Units) by Type (2012-2017)
Table Southeast Asia Patient Derived Xenograft/PDX Models Sales Volume Market Share by Type (2012-2017)
Figure Southeast Asia Patient Derived Xenograft/PDX Models Sales Volume Market Share by Type in 2016
Table Southeast Asia Patient Derived Xenograft/PDX Models Sales Volume (K Units) by Applications (2012-2017)
Table Southeast Asia Patient Derived Xenograft/PDX Models Sales Volume Market Share by Application (2012-2017)
Figure Southeast Asia Patient Derived Xenograft/PDX Models Sales Volume Market Share by Application in 2016
Figure Australia Patient Derived Xenograft/PDX Models Sales (K Units) and Growth Rate (2012-2017)
Figure Australia Patient Derived Xenograft/PDX Models Revenue (Million USD) and Growth Rate (2012-2017)
Figure Australia Patient Derived Xenograft/PDX Models Sales Price (USD/Unit) Trend (2012-2017)
Table Australia Patient Derived Xenograft/PDX Models Sales Volume (K Units) by Type (2012-2017)
Table Australia Patient Derived Xenograft/PDX Models Sales Volume Market Share by Type (2012-2017)
Figure Australia Patient Derived Xenograft/PDX Models Sales Volume Market Share by Type in 2016
Table Australia Patient Derived Xenograft/PDX Models Sales Volume (K Units) by Applications (2012-2017)
Table Australia Patient Derived Xenograft/PDX Models Sales Volume Market Share by Application (2012-2017)
Figure Australia Patient Derived Xenograft/PDX Models Sales Volume Market Share by Application in 2016
Table Crown Bioscience Inc. Patient Derived Xenograft/PDX Models Basic Information List
Table Crown Bioscience Inc. Patient Derived Xenograft/PDX Models Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Crown Bioscience Inc. Patient Derived Xenograft/PDX Models Sales (K Units) and Growth Rate (2012-2017)
Figure Crown Bioscience Inc. Patient Derived Xenograft/PDX Models Sales Market Share in Asia-Pacific (2012-2017)
Figure Crown Bioscience Inc. Patient Derived Xenograft/PDX Models Revenue Market Share in Asia-Pacific (2012-2017)
Table the Jackson Laboratory Patient Derived Xenograft/PDX Models Basic Information List
Table the Jackson Laboratory Patient Derived Xenograft/PDX Models Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure the Jackson Laboratory Patient Derived Xenograft/PDX Models Sales (K Units) and Growth Rate (2012-2017)
Figure the Jackson Laboratory Patient Derived Xenograft/PDX Models Sales Market Share in Asia-Pacific (2012-2017)
Figure the Jackson Laboratory Patient Derived Xenograft/PDX Models Revenue Market Share in Asia-Pacific (2012-2017)
Table Champions Oncology, Inc. Patient Derived Xenograft/PDX Models Basic Information List
Table Champions Oncology, Inc. Patient Derived Xenograft/PDX Models Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Champions Oncology, Inc. Patient Derived Xenograft/PDX Models Sales (K Units) and Growth Rate (2012-2017)
Figure Champions Oncology, Inc. Patient Derived Xenograft/PDX Models Sales Market Share in Asia-Pacific (2012-2017)
Figure Champions Oncology, Inc. Patient Derived Xenograft/PDX Models Revenue Market Share in Asia-Pacific (2012-2017)
Table Charles River Laboratories International, Inc. Patient Derived Xenograft/PDX Models Basic Information List
Table Charles River Laboratories International, Inc. Patient Derived Xenograft/PDX Models Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Charles River Laboratories International, Inc. Patient Derived Xenograft/PDX Models Sales (K Units) and Growth Rate (2012-2017)
Figure Charles River Laboratories International, Inc. Patient Derived Xenograft/PDX Models Sales Market Share in Asia-Pacific (2012-2017)
Figure Charles River Laboratories International, Inc. Patient Derived Xenograft/PDX Models Revenue Market Share in Asia-Pacific (2012-2017)
Table WuXi Apptec Patient Derived Xenograft/PDX Models Basic Information List
Table WuXi Apptec Patient Derived Xenograft/PDX Models Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure WuXi Apptec Patient Derived Xenograft/PDX Models Sales (K Units) and Growth Rate (2012-2017)
Figure WuXi Apptec Patient Derived Xenograft/PDX Models Sales Market Share in Asia-Pacific (2012-2017)
Figure WuXi Apptec Patient Derived Xenograft/PDX Models Revenue Market Share in Asia-Pacific (2012-2017)
Table ONCODESIGN Patient Derived Xenograft/PDX Models Basic Information List
Table ONCODESIGN Patient Derived Xenograft/PDX Models Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure ONCODESIGN Patient Derived Xenograft/PDX Models Sales (K Units) and Growth Rate (2012-2017)
Figure ONCODESIGN Patient Derived Xenograft/PDX Models Sales Market Share in Asia-Pacific (2012-2017)
Figure ONCODESIGN Patient Derived Xenograft/PDX Models Revenue Market Share in Asia-Pacific (2012-2017)
Table Horizon Discovery Group PLC Patient Derived Xenograft/PDX Models Basic Information List
Table Horizon Discovery Group PLC Patient Derived Xenograft/PDX Models Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Horizon Discovery Group PLC Patient Derived Xenograft/PDX Models Sales (K Units) and Growth Rate (2012-2017)
Figure Horizon Discovery Group PLC Patient Derived Xenograft/PDX Models Sales Market Share in Asia-Pacific (2012-2017)
Figure Horizon Discovery Group PLC Patient Derived Xenograft/PDX Models Revenue Market Share in Asia-Pacific (2012-2017)
Table Pharmatest Services Ltd. Patient Derived Xenograft/PDX Models Basic Information List
Table Pharmatest Services Ltd. Patient Derived Xenograft/PDX Models Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Pharmatest Services Ltd. Patient Derived Xenograft/PDX Models Sales (K Units) and Growth Rate (2012-2017)
Figure Pharmatest Services Ltd. Patient Derived Xenograft/PDX Models Sales Market Share in Asia-Pacific (2012-2017)
Figure Pharmatest Services Ltd. Patient Derived Xenograft/PDX Models Revenue Market Share in Asia-Pacific (2012-2017)
Table Hera Biolabs Patient Derived Xenograft/PDX Models Basic Information List
Table Hera Biolabs Patient Derived Xenograft/PDX Models Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Hera Biolabs Patient Derived Xenograft/PDX Models Sales (K Units) and Growth Rate (2012-2017)
Figure Hera Biolabs Patient Derived Xenograft/PDX Models Sales Market Share in Asia-Pacific (2012-2017)
Figure Hera Biolabs Patient Derived Xenograft/PDX Models Revenue Market Share in Asia-Pacific (2012-2017)
Table EPO Berlin-Buch GmbH Patient Derived Xenograft/PDX Models Basic Information List
Table EPO Berlin-Buch GmbH Patient Derived Xenograft/PDX Models Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure EPO Berlin-Buch GmbH Patient Derived Xenograft/PDX Models Sales (K Units) and Growth Rate (2012-2017)
Figure EPO Berlin-Buch GmbH Patient Derived Xenograft/PDX Models Sales Market Share in Asia-Pacific (2012-2017)
Figure EPO Berlin-Buch GmbH Patient Derived Xenograft/PDX Models Revenue Market Share in Asia-Pacific (2012-2017)
Table Xentech Patient Derived Xenograft/PDX Models Basic Information List
Table Urolead Patient Derived Xenograft/PDX Models Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price (USD/Unit) Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Patient Derived Xenograft/PDX Models
Figure Manufacturing Process Analysis of Patient Derived Xenograft/PDX Models
Figure Patient Derived Xenograft/PDX Models Industrial Chain Analysis
Table Raw Materials Sources of Patient Derived Xenograft/PDX Models Major Manufacturers in 2016
Table Major Buyers of Patient Derived Xenograft/PDX Models
Table Distributors/Traders List
Figure Asia-Pacific Patient Derived Xenograft/PDX Models Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure Asia-Pacific Patient Derived Xenograft/PDX Models Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Asia-Pacific Patient Derived Xenograft/PDX Models Price (USD/Unit) and Trend Forecast (2017-2022)
Table Asia-Pacific Patient Derived Xenograft/PDX Models Sales Volume (K Units) Forecast by Region (2017-2022)
Figure Asia-Pacific Patient Derived Xenograft/PDX Models Sales Volume Market Share Forecast by Region (2017-2022)
Figure Asia-Pacific Patient Derived Xenograft/PDX Models Sales Volume Market Share Forecast by Region in 2022
Table Asia-Pacific Patient Derived Xenograft/PDX Models Revenue (Million USD) Forecast by Region (2017-2022)
Figure Asia-Pacific Patient Derived Xenograft/PDX Models Revenue Market Share Forecast by Region (2017-2022)
Figure Asia-Pacific Patient Derived Xenograft/PDX Models Revenue Market Share Forecast by Region in 2022
Figure China Patient Derived Xenograft/PDX Models Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure China Patient Derived Xenograft/PDX Models Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Japan Patient Derived Xenograft/PDX Models Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure Japan Patient Derived Xenograft/PDX Models Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure South Korea Patient Derived Xenograft/PDX Models Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure South Korea Patient Derived Xenograft/PDX Models Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Taiwan Patient Derived Xenograft/PDX Models Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure Taiwan Patient Derived Xenograft/PDX Models Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure India Patient Derived Xenograft/PDX Models Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure India Patient Derived Xenograft/PDX Models Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Patient Derived Xenograft/PDX Models Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Patient Derived Xenograft/PDX Models Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Australia Patient Derived Xenograft/PDX Models Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure Australia Patient Derived Xenograft/PDX Models Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Asia-Pacific Patient Derived Xenograft/PDX Models Sales (K Units) Forecast by Type (2017-2022)
Figure Asia-Pacific Patient Derived Xenograft/PDX Models Sales Market Share Forecast by Type (2017-2022)
Table Asia-Pacific Patient Derived Xenograft/PDX Models Revenue (Million USD) Forecast by Type (2017-2022)
Figure Asia-Pacific Patient Derived Xenograft/PDX Models Revenue Market Share Forecast by Type (2017-2022)
Table Asia-Pacific Patient Derived Xenograft/PDX Models Price (USD/Unit) Forecast by Type (2017-2022)
Table Asia-Pacific Patient Derived Xenograft/PDX Models Sales (K Units) Forecast by Application (2017-2022)
Figure Asia-Pacific Patient Derived Xenograft/PDX Models Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources